Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P G Strange

Showing results (51-60 of 151) with videos related to

Pageof 16
Sort By:
Biochemical Pharmacology|November 15, 1985
Antisera raised against the drug haloperidolR Juszczak, P G Strange
The Biochemical Journal|September 15, 1986
Attempts to obtain anti(D2 dopamine receptor) antibodies via the anti-idiotypic routeW M Abbott, P G Strange
The Biochemical Journal|January 15, 1992
Importance of thiol groups in ligand binding to D2 dopamine receptors from brain and anterior pituitary glandP L Chazot, P G Strange
Biochemical Pharmacology|July 28, 1999
Comparison of the ability of dopamine receptor agonists to inhibit forskolin-stimulated adenosine 3'5'-cyclic monophosphate (cAMP) accumulation via D2L (long isoform) and D3 receptors expressed in Chinese hamster ovary (CHO) cellsD A Hall, P G Strange
Biochemical Society Transactions|January 1, 1978
The binding of the muscarinic receptor antagonist, [3-3H]quinuclidinyl benzilate, to Torpedo marmorata membrane fragments [proceedings]M R Pickard, P G Strange
Biochemical Pharmacology|July 22, 1992
Studies on the structure of the ligand-binding site of the brain D1 dopamine receptorC M Hollis, P G Strange
Biochemical Society Transactions|February 1, 1995
Allosteric regulation of the rat D2 dopamine receptorS R Hoare, P G Strange
Bioscience Reports|November 1, 1984
The use of a prostacyclin analogue, [3H]iloprost, for studying prostacyclin-binding sites on human platelets and neuronal hybrid cellsJ M Hall, P G Strange
British Journal of Pharmacology|June 1, 1997
Evidence that antipsychotic drugs are inverse agonists at D2 dopamine receptorsD A Hall, P G Strange
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1976
Receptor interactions in a signalling system: competition between ribose receptor and galactose receptor in the chemotaxis responseP G Strange, D E Koshland
Pageof 16

Showing results (51-60 of 151) with videos related to

Sort By:
Pageof 16
Biochemical Pharmacology|November 15, 1985
Antisera raised against the drug haloperidolR Juszczak, P G Strange
The Biochemical Journal|September 15, 1986
Attempts to obtain anti(D2 dopamine receptor) antibodies via the anti-idiotypic routeW M Abbott, P G Strange
The Biochemical Journal|January 15, 1992
Importance of thiol groups in ligand binding to D2 dopamine receptors from brain and anterior pituitary glandP L Chazot, P G Strange
Biochemical Pharmacology|July 28, 1999
Comparison of the ability of dopamine receptor agonists to inhibit forskolin-stimulated adenosine 3'5'-cyclic monophosphate (cAMP) accumulation via D2L (long isoform) and D3 receptors expressed in Chinese hamster ovary (CHO) cellsD A Hall, P G Strange
Biochemical Society Transactions|January 1, 1978
The binding of the muscarinic receptor antagonist, [3-3H]quinuclidinyl benzilate, to Torpedo marmorata membrane fragments [proceedings]M R Pickard, P G Strange
Biochemical Pharmacology|July 22, 1992
Studies on the structure of the ligand-binding site of the brain D1 dopamine receptorC M Hollis, P G Strange
Biochemical Society Transactions|February 1, 1995
Allosteric regulation of the rat D2 dopamine receptorS R Hoare, P G Strange
Bioscience Reports|November 1, 1984
The use of a prostacyclin analogue, [3H]iloprost, for studying prostacyclin-binding sites on human platelets and neuronal hybrid cellsJ M Hall, P G Strange
British Journal of Pharmacology|June 1, 1997
Evidence that antipsychotic drugs are inverse agonists at D2 dopamine receptorsD A Hall, P G Strange
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1976
Receptor interactions in a signalling system: competition between ribose receptor and galactose receptor in the chemotaxis responseP G Strange, D E Koshland
Pageof 16